Category: Cardiac Rhythm ManagementSyndicate content

FDA to require PMAs for automated external defibrillators

January 28, 2015 by Brad Perriello

The FDA says it will require automated external defibrillators to undergo its strict pre-market approval process.

FDA to require PMAs for automated external defibrillators

St. Jude Medical's Q4, 2014 profits surge

January 28, 2015 by Brad Perriello

St. Jude Medical's 4th-quarter and 2014 profits surge as its sales and earnings meet expectations on Wall Street.

St. Jude Medical's Q4, 2014 profits surge

FDA approves St. Jude Medical's FlexAbility catheter

January 27, 2015 by Brad Perriello

The FDA approves St. Jude Medical's FlexAbility ablation catheter for treating cardiac fibrillation.

FDA approves St. Jude Medical's FlexAbility catheter

mHealth: AliveCor wins CE Mark for new afib algorithm

January 23, 2015 by Mark Hollmer

AliveCor, with CE Mark in hand, will roll out an updated app in the United Kingdom and Ireland that detects atrial fibrillation.

mHealth: AliveCor wins CE Mark for new afib algorithm

AliveCor said it plans to launch the latest version of its app to detect atrial fibrillation in the U.K. and Ireland after winning CE Mark approval in the European Union for the updated tech.

Medtronic launches European trial for Arctic Front device

January 8, 2015 by Brad Perriello

Medtronic launches a European clinical trial to evalute its Arctic Front Advance cryoablation balloon as a front-line treatment for atrial fibrillation.

Medtronic readies European trial for Artic Front device

St. Jude Medical launches v-tach ablation trial

January 7, 2015 by Brad Perriello

St. Jude Medical launches a clinical trial to evaluate the use of ablation and cardiac rhythm management devices in treating ventricular tachycardia.

St. Jude Medical launches v-tach ablation trial

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

CardioFocus raises $32m, inks Japanese distribution deal

January 7, 2015 by Brad Perriello

CardioFocus reports a funding round worth nearly $32 million and inks a Japanese distribution deal for its HeartLight laser ablation system for treating atrial fibrillation.

CardioFocus raises $32m, inks Japanese distribution deal

this week reported a funding round worth nearly $32 million and said it inked a distribution deal in Japan for its HeartLight laser ablation system for treating atrial fibrillation.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.